Tailored drug-release from multi-functional polymer-peptide hybrid vesicles

Abstract : The synthetic semi-crystalline polymer poly(trimethylene carbonate) PTMC50 was linked to the synthetic poly(amino acid) poly(glutamic acid) (PGA(15)) using the peptide PVGLIG, known to be selectively cleaved by the tumor-associated enzyme matrix metalloproteinase 2 (MMP-2), by a combination of thiol-ene coupling and ring-opening polymerization. Stable, monodisperse, sub-micron sized polymersomes were subsequently obtained by self-assembly and characterized by dynamic and static light scattering (DLS and SLS) and transmission electron microscopy (TEM). These vesicles showed selective degradation in the presence of MMP-2 as probed by DLS. The model drug imipramine hydrochloride was loaded at 35% encapsulation efficiency by co-precipitation and displayed controlled drug-release behavior. Drug release rates showed several fold increases when exposed to pH, temperature and most significantly, to the tumor-associated enzyme MMP-2. Such structures, bearing precise location of the cleavable peptide sequence, may hold promise as future specific and controlled drug-delivery systems. (C) 2014 Elsevier Ltd. All rights reserved.
Document type :
Journal articles
Complete list of metadatas

Contributor : Dominique Richard <>
Submitted on : Wednesday, September 7, 2016 - 4:19:24 PM
Last modification on : Monday, January 15, 2018 - 1:38:02 PM




Daniel Bacinello, Elisabeth Garanger, Daniel Taton, Kam Chiu Tam, Sébastien Lecommandoux. Tailored drug-release from multi-functional polymer-peptide hybrid vesicles . European Polymer Journal, Elsevier, 2015, 62, pp.363-373. ⟨10.1016/j.eurpolymj.2014.09.001 ⟩. ⟨hal-01361862⟩



Record views